We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




MIS Boosts Use of New Techniques in Europe

By HospiMedica staff writers
Posted on 28 Apr 2005
The growing popularity of minimally invasive surgery (MIS) in Europe has generated immense market potential for enabling technologies such as robot-assisted surgery (RAS) and image-guided surgery (IGS), according to a new report from Frost & Sullivan (Palo Alto, CA, USA), an international consulting company.

The European IGS market was estimated at U.S.$93.6 million in 2004, with a projected 13.9% growth rate over 2004-2008. More...
The RAS market, estimated at $18 million, is forecast to grow 3.6% over the same period.

Image-guided navigation during MIS provides the surgeon with three-dimensional (3D) navigation and with the capability of altering images for greater detail. This results in higher accuracy, shorter operation times, and quicker recovery. This type of procedure is likely to benefit patients unable to withstand major surgery. In a similar manner, robotic assistants aid the performance of steadier surgical techniques, decrease surgery times, guide more precise procedures, and permit staff to carry out more dynamic tasks.

Currently, IGS is being deployed in neurologic, orthopedic, ear-nose-throat surgeries, dental applications, and emerging maxillo-facial surgery. Robotic applications are designed for general, cardiac, orthopedic, and brain surgery. One of the key deterrents to market growth is the high cost of installation and capital equipment, with many hospitals expecting free upgrades.

"Further technological improvements, greater integration along with more open and flexible platforms are likely to broaden the number of application areas, thereby spurring market growth,” noted Kavitha Ravikumar, a research analyst with Frost & Sullivan. "Manufacturers need to concentrate on surgical procedures where the product provides maximum benefit as well as clearly demonstrates how these products provide value for money in terms of investment versus outcome.”


Related Links:
Frost & Sullivan

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.